News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
92 Results
Type
Article (15)
Press Release (77)
Section
Business (36)
Deals (7)
Drug Development (9)
FDA (1)
Job Trends (2)
News (48)
Tag
Alliances (2)
Approvals (1)
Best Places to Work (1)
Cancer (5)
Career advice (1)
Clinical research (14)
Collaboration (2)
C-suite (2)
Data (3)
Depression (1)
Earnings (18)
Events (15)
Executive appointments (2)
FDA (1)
GLP-1 (1)
Immuno-oncology (1)
IPO (6)
Job creations (1)
Leadership (1)
Lung cancer (1)
Mergers & acquisitions (1)
Neuroscience (1)
People (21)
Phase 1 (13)
Phase 2 (1)
Phase 3 (1)
Pipeline (5)
Preclinical (1)
Prostate cancer (2)
Psychedelics (1)
Startups (3)
Date
Last 30 days (3)
Last 365 days (16)
2026 (3)
2025 (14)
2024 (16)
2023 (11)
2022 (24)
2021 (22)
2020 (2)
Location
Asia (3)
California (22)
Europe (3)
North Carolina (1)
Southern California (21)
United States (23)
92 Results for "janux".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cancer
BMS Bets $850M on Janux’s Tumor-Activated Drugs, Deepening Cancer Investments
The partnership will allow BMS to advance a T cell–based therapy that is only activated once in the vicinity of a tumor.
January 22, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Janux Therapeutics Appoints William Go, M.D., Ph.D., as Chief Medical Officer
January 27, 2026
·
6 min read
Press Releases
Janux Therapeutics Provides Program Update on Ongoing Phase 1 JANX008 Study
December 24, 2025
·
5 min read
Press Releases
Janux Therapeutics Announces Collaboration and Exclusive Worldwide License Agreement with Bristol Myers Squibb to Develop a Novel Tumor-Activated Therapeutic for Solid Tumors
January 22, 2026
·
5 min read
Press Releases
Janux Therapeutics Reports Third Quarter 2025 Financial Results and Business Highlights
November 6, 2025
·
7 min read
Press Releases
Janux Announces Encouraging Efficacy and Safety Profile from Ongoing Phase 1 Clinical Trial for JANX007 in mCRPC
December 2, 2025
·
7 min read
Press Releases
Janux Therapeutics to Host Virtual Event Discussing Updated Phase 1a and Phase 1b Clinical Data for JANX007 in mCRPC
November 24, 2025
·
4 min read
Press Releases
Janux Therapeutics Announces Clinical Milestone Achievement in TRACTr Collaboration With Merck
August 5, 2025
·
5 min read
Press Releases
Janux Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights
August 8, 2025
·
8 min read
Press Releases
Janux Therapeutics to Host Virtual R&D Day on July 24, 2025
July 18, 2025
·
4 min read
1 of 10
Next
